| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/11/2012 | CN102309693A Preparation method of total flavones of bitter bamboo leaves |
| 01/11/2012 | CN102309657A Ginseng astragalus ruton capsules and preparation method thereof |
| 01/11/2012 | CN102309635A Traditional Chinese medicine preparation for treating diabetes |
| 01/11/2012 | CN102309632A Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 01/11/2012 | CN102309630A Processing method for toxicity reduction and efficacy enhancement of rhizoma alismatis |
| 01/11/2012 | CN102309610A Toxin expelling liquid for clearing human body toxins |
| 01/11/2012 | CN102309607A Chinese medicine decoction for treating diabetic retinopathy and preparation method thereof |
| 01/11/2012 | CN102309575A Application of medicinal composition in preparing medicament for treating diabetic complication |
| 01/11/2012 | CN102309524A Processing method of snow frog compound nutrient preparation for pregnant women |
| 01/11/2012 | CN102309497A Pharmaceutical composition for cardio cerebrovascular diseases |
| 01/11/2012 | CN102309496A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases |
| 01/11/2012 | CN102309494A Medicinal application of pristimerin as inflammatory cytokine inhibitor |
| 01/11/2012 | CN102309489A Medicine for treating diabetic nephropathy |
| 01/11/2012 | CN102309476A Fenofibrate composition |
| 01/11/2012 | CN102309475A Levocarnitine for injection and preparation method thereof |
| 01/11/2012 | CN102309467A Preparation method of atorvastatin calcium capsule |
| 01/11/2012 | CN102309464A Folic acid tablet and preparation method thereof |
| 01/11/2012 | CN102309462A Atorvastatin calcium tablet |
| 01/11/2012 | CN102309453A Exenatide multivesicular liposome and preparation method thereof |
| 01/11/2012 | CN102309452A Fluvastatin sodium liposome solid preparation |
| 01/11/2012 | CN102309446A Silver-carrying nanometer cod liver oil microemulsion and low energy consumption preparation process thereof |
| 01/11/2012 | CN102309443A Small cluster water zinc supplementation oral liquid, and preparation method and application thereof |
| 01/11/2012 | CN102308989A Health care composition of formica rufa, grape and propolis extracts |
| 01/11/2012 | CN102308941A Diet green coarse cereal food and preparation method thereof |
| 01/11/2012 | CN102308898A Medicinal fresh Chinese herb tea containing Chimonanthus fragrans, and preparation method and usage thereof |
| 01/11/2012 | CN102068453B Stable complex vitamin composition and preparation method thereof |
| 01/11/2012 | CN102058697B Health product for adjuvant therapy of heart cerebrovascular diseases and preparation method thereof |
| 01/11/2012 | CN102008440B Solid preparation of atorvastatin calcium liposome |
| 01/11/2012 | CN101919901B Application of total aglycone of Gleditsia sinensis Lam in preparation of alpha-glucosidase inhibitor drugs |
| 01/11/2012 | CN101912484B Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia |
| 01/11/2012 | CN101843665B Fig leaf extract lozenges |
| 01/11/2012 | CN101843613B Vitamin EC chewable tablets with high stability and preparation method thereof |
| 01/11/2012 | CN101810735B Method for extracting total flavone from ampelopsis grossedentata |
| 01/11/2012 | CN101757391B Medicine composition for treating cardio-cerebral-vascular diseases and preparation method and application thereof |
| 01/11/2012 | CN101700225B Fat emulsion injection and production method thereof |
| 01/11/2012 | CN101679297B LXR and FXR modulators |
| 01/11/2012 | CN101671293B Alpha-glycosidase inhibitor compound in silkworm excrement total alkaloid and application thereof |
| 01/11/2012 | CN101642245B Lipid-lowering and toxin-removing decoction |
| 01/11/2012 | CN101632509B Medicinal treatment shoe |
| 01/11/2012 | CN101590128B Lipid regulating and antioxidant effect-based method for evaluating quality of Jiangzhining |
| 01/11/2012 | CN101548989B Mactra veneriformis extract, preparation method and application thereof |
| 01/11/2012 | CN101397327B Use of dihydro ginsenoside Rg2 |
| 01/11/2012 | CN101312725B Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 01/11/2012 | CN101305009B 氮杂取代的螺环衍生物 Aza-substituted spiro derivatives of |
| 01/11/2012 | CN101258924B Postpartum recuperating body shaping soup |
| 01/11/2012 | CN101190281B Prune tree extract and preparation method and application thereof |
| 01/11/2012 | CN101138549B Mitiglinide calcium self-microemulsifying drug delivery system |
| 01/11/2012 | CN101049123B Method for preparing tea of natural pine needle powder |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8092840 Dietary supplement and a method to enhance sleep and lucid dreaming |
| 01/10/2012 | US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 |
| 01/10/2012 | CA2608180C Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 01/10/2012 | CA2536187C Pharmaceutical composition comprising a combination of metformin and a statin |
| 01/10/2012 | CA2508042C Pyridine/pyrazine-2-carboxamide derivatives and uses thereof |
| 01/10/2012 | CA2454339C Methods for preventing antipsychotic-induced weight gain |
| 01/10/2012 | CA2376017C Potassium calcium citrate compositions and methods for production |
| 01/05/2012 | WO2012003392A1 Fused heterocyclic compounds as ion channel modulators |
| 01/05/2012 | WO2012002922A1 Synergistic pharmaceutical formulations of colesevelam and fenofibrate |
| 01/05/2012 | WO2012002921A1 Multiple dosage forms comprising fenofibrate or fenofibric acid in combination with hmg co a reductase inhibitors such as statins |
| 01/05/2012 | WO2012002919A1 Pharmaceutical formulations comprising atorvastatin and aspirin |
| 01/05/2012 | WO2012002918A1 Formulation for osteoporosis |
| 01/05/2012 | WO2012002777A2 Composition containing plant extracts for inhibiting the granule secretion of mast cells |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012002464A1 ω3 FATTY ACID COMPOUND PREPARATION |
| 01/05/2012 | WO2012002328A1 Blood hdl level increasing agent or anti-arteriosclerotic agent |
| 01/05/2012 | WO2012001201A1 Ingredient reconstituted from dry fruit and/or carob |
| 01/05/2012 | WO2012001100A1 Enterovirus vaccines for preventing or treating type 1 diabetes (iii) |
| 01/05/2012 | WO2012001098A1 Diagnostic assay for type 1 diabetes |
| 01/05/2012 | WO2012001020A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | WO2012000499A1 New polymorphic form of a calcimimetic compound |
| 01/05/2012 | WO2012000498A1 New polymorphic form of a calcimimetic compound |
| 01/05/2012 | WO2012000377A1 Pharmaceutical composition comprising levocarnitine and dobesilate |
| 01/05/2012 | WO2012000212A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | WO2012000087A1 Compositions and methods for controlling blood glucose levels |
| 01/05/2012 | WO2012000048A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 01/05/2012 | WO2012000036A1 Treatment of abnormalities of glucose metabolism with an antagonist of inhibitor of differentiation 1 |
| 01/05/2012 | WO2011130302A3 Method of treating obesity using antioxidant inflammation modulators |
| 01/05/2012 | WO2011093664A3 Anti-obesity composition containing (1s,2s,3s,4s)-5-aminocyclopentane-1,2,3,4-tetraol |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | US20120005127 Methods for improvement of beta cell function |
| 01/05/2012 | US20120004720 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 01/05/2012 | US20120004316 Treating impulse control disorders with catechol-o-methyl-transferase inhibitors |
| 01/05/2012 | US20120004315 Selective Estrogen Receptor Modulator |
| 01/05/2012 | US20120004312 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004310 Non-peptide bdnf neurotrophin mimetics |
| 01/05/2012 | US20120004291 Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof |
| 01/05/2012 | US20120004287 Therapeutic agent comprising vasohibin |
| 01/05/2012 | US20120004286 Long-acting veterinary polypeptides and methods of producing and administering same |
| 01/05/2012 | US20120004276 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3 phosphate acyltransferase 1 (mtgpat1) |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004267 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | US20120004260 Inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds and methods of treatment thereof |
| 01/05/2012 | US20120004252 New ccr2 receptor antagonists and uses thereof |
| 01/05/2012 | US20120004246 Purinyl derivatives and their use as potassium channel modulators |
| 01/05/2012 | US20120004234 Phthalazine-containing antidiabetic compounds |
| 01/05/2012 | US20120004231 Substituted Pyridazine Derivatives |